In 2013, Abraxane (nanoparticle albumin — bound formulation of paclitaxel) was approved in combination with gemcitabine for metastatic pancreatic cancer. (rdmag.com)
Influence of gemcitabine chemotherapy on the microbiota of pancreatic cancer xenografted mice. (microbiomedigest.com)
Among patients with pancreatic cancer who had surgery for removal of the cancer, treatment with the drug gemcitabine for 6 months resulted in increased overall survival as well as disease - free survival, compared with observation alone, according to a study in the October 9 issue of JAMA. (sciencedaily.com)